For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome

Hello. We're improving abcam.com and we'd welcome your feedback.

Hello. We're improving abcam.com and we'd welcome your feedback.

Infomation icon

We haven't added this to the BETA yet

New BETA website

New BETA website

Hello. We're improving abcam.com and we'd welcome your feedback.

Take a look at our BETA site and see what we’ve done so far.

Switch on our new BETA site

Now available

Search and browse selected products

  • A selection of primary antibodies

Purchase these through your usual distributor

In the coming months

  • Additional product types
  • Supporting content
  • Sign in to your account
  • Purchase online
United States
Your country/region is currently set to:

If incorrect, please enter your country/region into the box below, to view site information related to your country/region.

Call (888) 77-ABCAM (22226) or contact us
Need help? Contact us

  • My account
  • Sign out
Sign in or Register with us

Welcome

Sign in or

Don't have an account?

Register with us
My basket
Quick order
Abcam homepage

  • Research Products
    By product type
    Primary antibodies
    Secondary antibodies
    ELISA and Matched Antibody Pair Kits
    Cell and tissue imaging tools
    Cellular and biochemical assays
    Proteins and Peptides
    By product type
    Proteomics tools
    Agonists, activators, antagonists and inhibitors
    Cell lines and Lysates
    Multiplex miRNA assays
    Multiplex Assays
    By research area
    Cancer
    Cardiovascular
    Cell Biology
    Epigenetics
    Metabolism
    Developmental Biology
    By research area
    Immunology
    Microbiology
    Neuroscience
    Signal Transduction
    Stem Cells
  • Customized Products & Partnerships
    Customized Products & Partnerships

    Customized products and commercial partnerships to accelerate your diagnostic and therapeutic programs.

    Customized products

    Partner with us

  • Support
    Support hub

    Access advice and support for any research roadblock

    View support hub

    Protocols

    Your experiments laid out step by step

    View protocols

  • Events
    • Conference calendar
    • Cancer
    • Cardiovascular
    • Epigenetics & Nuclear signaling
    • Immunology
    • Neuroscience
    • Stem cells
    • Tradeshows
    • Scientific webinars
    Keep up to date with the latest events

    Full event breakdown with abstracts, speakers, registration and more

    View global event calendar

  • Pathways
    Cell signalling pathways

    View all pathways

    View all interactive pathways

Products by research area:
  • Cancer
  • Cardiovascular
  • Cell Biology
  • Epigenetics & Nuclear Signaling
  • Developmental Biology
  • Immunology
  • Metabolism
  • Microbiology
  • Neuroscience
  • Signal Transduction
  • Stem Cells

Abcam’s new anti-PD-L1 antibody enables deeper insights into cancer immunology research

Clone 28-8 provides researchers with knockout validated antibody to critical checkpoint inhibitor

Cambridge, UK, 06 October 2015: Abcam plc, a global leader in the supply of life sciences research tools, today announced the launch of its anti-PD-L1 primary antibody (clone 28-8). Produced using Abcam’s RabMAb® recombinant monoclonal antibody technology, the clone offers highly specific and reproducible antigen recognition to a checkpoint inhibitor critical to current cancer immunology research.

 

Programmed-death ligand 1 (PD-L1), also known as CD274 and B7-H1, can be expressed on the surface of tumour cells and binds to PD-1 receptors found on T-cells. This mechanism is used by tumour cells to evade detection and removal by the immune system. Abcam’s highly specific anti-PD-L1 clone (clone 28-8) has been knockout validated and tested in key applications such as Immunohistochemisty (IHC)1 and Flow Cytometry providing researchers with trusted data and ensuring the accuracy of their results. Developed through a research collaboration with a major pharma company, the PD-L1 antibody will give researchers a high quality tool to further explore the role of PD-L1 in disease progression and treatment. An IHC assay using clone 28-8 has been used to determine PD-L1 expression in clinical trials. Aside from cancer immunology, PD-L1 has also been implicated as having a role in autoimmune diseases and neurological disease.

 

Abcam is planning further industry partnerships, applying its RabMAb primary antibody technology to make emerging biomarkers available for major disease areas for both research and diagnostic purposes, including other checkpoint inhibitors. RabMAb primary antibodies offer researchers the sensitivity of the rabbit immune system combined with the specificity and consistency of monoclonal antibodies.

 

Alan Hirzel, CEO of Abcam, said “We want to make specialised, validated reagents, with a translational focus, available for basic research. Collaborating with leading pharmaceutical companies to develop antibodies to critical biomarkers is one important part of this strategy.”

 

“Our industry partners are working in disease areas with high unmet need, so we are ideally placed to combine their specialist understanding with our novel RabMAb technology to make clones accessible to researchers. In fact, our anti-PD-L1 antibody is highly cited in the market particularly for immunohistochemistry.”

 

The PD-L1 RabMAb antibody (clone 28-8, Ab205921) antibody can now be purchased from Abcam globally. To find out more, visit https://www.abcam.com/pdl1  

  1. Phillips, T., et al., 2015. Development of an automated PD-L1 immunohistochemistry (IHC) assay for non–small cell lung cancer. Applied Immunohistochemistry & Molecular Morphology. 23(8), pp 541-9.
 

Contacts:

Abcam
Francesca Axe
T: +44 (0) 1223 696000

 

Media enquiries
Dr. Lynne Trowbridge / Tim Watson
Instinctif Partners
T: +44 (0)20 7457 2861 / +44 (0)20 7866 7861
E: abcam@instinctif.com

 

About Abcam

Abcam plc is a global leader in the supply of life science research tools, with a wide range of products and expert technical support, enabling scientists to analyse living cells at the molecular level and to improve the understanding of health and disease.

 

Abcam is committed to providing scientists with an extensive choice of reagents and tools, with the most comprehensive, honest and up-to-date datasheets and customer reviews, fast delivery and helpful customer service & technical support. The Company’s catalogue evolves with scientific research trends and is growing each year to provide customers with products to meet their research needs. The range now includes primary and secondary antibodies, proteins, peptides, lysates, biochemicals, immunoassays and other kits. Abcam also supports its customers by hosting a range of global scientific events, forums and webinars, providing opportunities for scientists to get together and present their work.

 

Headquartered in Cambridge, UK, Abcam has nine global subsidiary offices enabling local services and multi-language support to over 100 countries. The Company was founded in 1998, and now employs over 800 people. Abcam was admitted to AIM in 2005 (AIM: ABC).

 

Visit Abcam to find out more

Get resources and offers direct to your inbox Sign up
A-Z by research area
  • Cancer
  • Cardiovascular
  • Cell biology
  • Developmental biology
  • Epigenetics & Nuclear signaling
  • Immunology
  • Metabolism
  • Microbiology
  • Neuroscience
  • Signal transduction
  • Stem cells
A-Z by product type
  • Primary antibodies
  • Secondary antibodies
  • Biochemicals
  • Isotype controls
  • Flow cytometry multi-color selector
  • Kits
  • Loading controls
  • Lysates
  • Peptides
  • Proteins
  • Slides
  • Tags and cell markers
  • Tools & Reagents
Help & support
  • Support
  • Make an Inquiry
  • Protocols & troubleshooting
  • Placing an order
  • RabMAb products
  • Biochemical product FAQs
  • Training
  • Browse by Target
Company
  • Corporate site
  • Investor relations
  • Company news
  • Careers
  • About us
  • Blog
Events
  • Tradeshows
  • Conferences
International websites
  • abcam.cn
  • abcam.co.jp

Join with us

  • LinkedIn
  • facebook
  • Twitter
  • YouTube
  • Terms of sale
  • Website terms of use
  • Cookie policy
  • Privacy policy
  • Legal
  • Modern slavery statement
© 1998-2023 Abcam plc. All rights reserved.